About KinoPharma
Kinopharma is a biopharmaceutical company
engaged in the discovery and development of small molecule drugs inhibiting
novel Ser/Thr kinases based on the proprietary platform technologies. Pipeline
includes kinase inhibitors for virus infection and CNS disorders:
1-1
DNA Virus Infection program (broad spectrum over HSV, CMV, HPV, adv)
1-2
RNA Virus Infection program (broad spectrum over HCV, influenza)
2.
CNS Disorder program: Down syndrome,
Alzheimer's disease
Kinopharma was established in 2005 as an academic spin-off company and its research laboratories are located
in Kyoto and Kobe, Japan.
|